Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Leukemia, Myelomonocytic, Chronic × Clear all

NCT03040401 2017-12-19

A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML)

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myelomonocytic, Chronic